MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.877
+0.004 (0.40%)
At close: Apr 28, 2026, 4:00 PM EDT
0.895
+0.018 (2.00%)
After-hours: Apr 28, 2026, 7:27 PM EDT
MaxCyte Stock Forecast
MXCT's stock price has decreased by -69.55% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MaxCyte stock have an average target of 5.50, with a low estimate of 5.00 and a high estimate of 6.00. The average target predicts an increase of 527.07% from the current stock price of 0.88.
Analyst Consensus: Buy
* Price targets were last updated on Mar 25, 2026.
Analyst Ratings
The average analyst rating for MaxCyte stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +470.06% | Mar 25, 2026 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 11, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +584.07% | Jul 22, 2025 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +926.11% | Mar 12, 2025 |
Financial Forecast
Revenue This Year
32.41M
from 33.03M
Decreased by -1.87%
Revenue Next Year
38.41M
from 32.41M
Increased by 18.50%
EPS This Year
-0.27
from -0.42
EPS Next Year
-0.25
from -0.27
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 39.0M | 44.1M | |||||
| Avg | 32.4M | 38.4M | |||||
| Low | 29.9M | 34.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 18.2% | 36.0% | |||||
| Avg | -1.9% | 18.5% | |||||
| Low | -9.5% | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.22 | -0.19 | |
| Avg | -0.27 | -0.25 | |
| Low | -0.30 | -0.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.